Cheng‐Ta Yang

10.0k citations
279 papers · 6.6k · 2 hit papers · h-index 43

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Lung Cancer Treatments and Mutations 92
    • Lung Cancer Diagnosis and Treatment 24
    • Respiratory Support and Mechanisms 17
    • Gastric Cancer Management and Outcomes 13
    • Colorectal Cancer Treatments and Studies 23
    • Lung Cancer Research Studies 20
    • Cancer Immunotherapy and Biomarkers 14

Cheng‐Ta Yang

267 papers receiving 6.5k citations

Cheng‐Ta Yang's Hit Papers

Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography 2023 · 131 citations
1310+1+2Years since publication50100150200250

Peers

Cheng‐Ta Yang
Comparison fields: 5 of 146
  • Pulmonary and Respiratory Medicine 2.2k
  • Oncology 1.5k
  • Cancer Research 522
  • Nephrology 204
  • Pathology and Forensic Medicine 396
Replace Aliya N. Husain with:
Aliya N. Husain United States
David Goldenberg United States
Edmond Sabo Israel
Li Chen China
Isabelle Salmon Belgium
Mark R. Nicolls United States
Dirk Westermann Germany
Nicholas Syn Singapore
Roland Andersson Sweden
Antti Saraste Finland
Cheng‐Ta Yang relative to Aliya N. Husain United States Aliya N. Husain's profile →
Citations per field
00.5×3.5×
Aliya N. Husain · 1×
Citations per year

Countries citing papers authored by Cheng‐Ta Yang

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Ta Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Ta Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Ta Yang more than expected).

Fields of papers citing papers by Cheng‐Ta Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Ta Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Ta Yang. The network helps show where Cheng‐Ta Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Cheng‐Ta Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cheng‐Ta Yang Line = papers co-authored together Cheng‐Ta Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 279 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study
Hit paper breakdown →
2022261
2 2008236
3 2015186
4 2019172
5 2006157
6 2019153
7 2005144
8 2021142
9
Sybil: A Validated Deep Learning Model to Predict Future Lung Cancer Risk From a Single Low-Dose Chest Computed Tomography
Hit paper breakdown →
2023131
10 2008112
11 201698
12 200096
13
ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
200094
14 201185
15 202084
16 201783
17 201881
18 201580
19 201479
20 200778

About Cheng‐Ta Yang

Cheng‐Ta Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Physiology, having authored 279 papers that have together received 6.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (92 papers), Lung Cancer Diagnosis and Treatment (24 papers), Colorectal Cancer Treatments and Studies (23 papers), Lung Cancer Research Studies (20 papers), Respiratory Support and Mechanisms (17 papers), Cancer Immunotherapy and Biomarkers (14 papers), Gastric Cancer Management and Outcomes (13 papers) and Obstructive Sleep Apnea Research (11 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Oncology (1.5k citations), Cancer Research (522 citations), Nephrology (204 citations) and Pathology and Forensic Medicine (396 citations). Cheng‐Ta Yang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Gur P. Kaushal, David M. Jablons, Varsha Kaushal, Liang You, Ping‐Chih Hsu, Sudhir V. Shah, Kuo‐Chin Kao, Li‐Fu Li, Chung-Chi Huang and Christian Herzog. Their work appears in journals such as Annals of Oncology, PLoS ONE, Cancers, Journal of Clinical Oncology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact